“…Electrochemical detection platform has taken major contribution and have been proven to answer major challenges in particular for point-of-care cancer diagnostic. Highly sensitive immunosensor detections of biomarkers-including PSA (Chen et al, 2014;Mani et al, 2009;Yu et al, 2006), IL-6 (Malhotra et al, 2010), IL-8 (Munge et al, 2011), carcinoembryonic antigen (CEA) Lin et al, 2012;Qian et al, 2011), cancer antigens (e.g., CA-125, CA-153, CA-199) (Cui et al, 2014;Wilson and Nie, 2006), and α-feto-protein (AFP) (Liu et al, 2015;Du et al, 2010;Lai et al, 2009;) Ă have been reported employing different electrochemical methods and signal amplification techniques. Most of the system relied on sandwich-type reaction, which offers high selectivity and hence limited crosstalk and interfering signal.…”